Product How it works Pricing Blog FAQ About Contact
Gilead Sciences

Gilead Sciences (NASDAQ: GILD) free cash flow

Gilead Sciences reported free cash flow of $9,456m for fiscal 2025: $10,019m of operating cash flow minus $563.0m of capital expenditure. That is 8.2% less than in fiscal 2024. It equals 32.1% of revenue.

Free cash flow, in millions of US dollars16,299201611,30820177,47620188,31920197,518202010,80520218,34420227,421202310,30520249,4562025
Embed this chart

Copy this code into your website or blog. The chart updates with each new annual report.

Free cash flow by fiscal year

Fiscal yearFree cash flowChangeOperating cash flowCapital expenditureShare of revenue
2025$9,456m−8.2%$10,019m$563.0m32.1%
2024$10,305m+38.9%$10,828m$523.0m35.8%
2023$7,421m−11.1%$8,006m$585.0m27.4%
2022$8,344m−22.8%$9,072m$728.0m30.6%
2021$10,805m+43.7%$11,384m$579.0m39.6%
2020$7,518m−9.6%$8,168m$650.0m30.5%
2019$8,319m+11.3%$9,144m$825.0m37.1%
2018$7,476m−33.9%$8,400m$924.0m33.8%
2017$11,308m−30.6%$11,898m$590.0m43.3%
2016$16,299m—$17,047m$748.0m53.6%

Free cash flow is operating cash flow minus capital expenditure, both from the cash flow statement in the same filing. The change compares each fiscal year with the one before and is not calculated when the previous year was negative. Figures are in millions of US dollars, except per-share amounts.

Questions about the free cash flow of Gilead Sciences

How much free cash flow did Gilead Sciences generate in fiscal 2025?
Gilead Sciences reported free cash flow of $9,456m for fiscal 2025. In fiscal 2024 it was free cash flow of $10,305m.
How is the free cash flow of Gilead Sciences calculated?
It is operating cash flow minus capital expenditure, both from the cash flow statement in its accounts: in fiscal 2025, $10,019m minus $563.0m.
What share of its revenue does Gilead Sciences turn into free cash flow?
In fiscal 2025, 32.1% of its revenue.
What was the best year for free cash flow at Gilead Sciences?
Of its last 10 fiscal years, fiscal 2016, with $16,299m.
Where do the figures for Gilead Sciences come from?
From the annual report (Form 10-K) that Gilead Sciences files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that Gilead Sciences files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Gilead Sciences: the Gilead Sciences page · annual accounts · revenue · net income · dividends paid · insider transactions.

Dividend per share of Gilead Sciences by fiscal year, with the filing behind every figure: Gilead Sciences dividend history.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.